Condition: High Risk Pregnancy · Congenital Heart Disease · Fetal Hydrops · Sponsor: Medical College of Wisconsin
Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) used thus far to successfully evaluate fetal arrhythmias, in order to discover potential hidden electrophysiologic abnormalities that could lead to fetal demise in five high-risk pregnancy conditions associated with fetal demise.
This description comes directly from the study's public registry record.
Mara C Koffarnus, MD · 414-266-4758 · mkoffarn@mcw.edu
Gretchen Eckstein · 414-266-3539 · geckstein@chw.org
Always discuss trial participation with your own doctor first.
| University of Wisconsin - Madison | Madison, Wisconsin, United States | Recruiting |
| Medical College of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03775954